Table 3.
Eight LBL epitopes selected for the designing of a multi-epitope vaccine.
| Protein | Epitopes | Position | Immunogenicity | Allergenicity | Antigenicity |
|---|---|---|---|---|---|
| Protein E6 | RDLCIVYRDGNPYAVC | 55 | 0.2 | Non-Allergen | 1.0 |
| Protein E7 | DRAHYNIVTFCCKCDS | 48 | 0.2 | Non-Allergen | 0.6 |
| STHVDIRTLEDLLMGT | 71 | 0.2 | Non-Allergen | 0.7 | |
| EBNA1 | HGRGRGRGRGRGGGRP | 39 | 0.4 | Non-Allergen | 1.2 |
| RGRGRGRGEKRPRSPS | 370 | 0.04 | Non-Allergen | 1.2 | |
| NEF | EEKVGFPVTPQVPLRP | 63 | 0.1 | Non-Allergen | 1.0 |
| GPGIRYPLTFGWCYKL | 130 | 0.3 | Non-Allergen | 0.7 | |
| EWRFDSRLAFHHVARE | 182 | 0.3 | Non-Allergen | 0.9 |